Related Experiment Videos
[The therapeutic prospects in glaucoma treatment]
Oftalmologia (Bucharest, Romania : 1990)
|March 1, 1993
Summary
New glaucoma drugs aim to lower eye pressure and protect vision by acting on the trabeculum and uveoscleral pathways. This review covers medications like prostaglandins and carbonic anhydrase inhibitors for optic nerve preservation.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Glaucoma treatment focuses on reducing intraocular pressure (ocular hypertonia).
- Preserving visual fields and optic nerve integrity is crucial for maintaining vision.
Purpose:
- To review current and emerging drug classes for glaucoma management.
- To categorize drugs based on their mechanism of action on ocular drainage pathways.
Summary:
- The review discusses drugs targeting the trabeculum, including parasympathomimetics, adrenaline, glucocorticoid antagonists, and colchicine.
- It also covers agents influencing ciliary processes, such as carbonic anhydrase inhibitors.
- Drugs acting on uveoscleral outflow, like prostaglandins, are also examined.
Impact:
- Provides a comprehensive overview of pharmacological interventions for glaucoma.
- Informs clinicians and researchers about diverse drug mechanisms for managing ocular hypertension and preserving optic nerve function.